Unlocking the future of diagnostics through advanced genetic testing and tailored laboratory solutions.
Valentis Group is proud to be one of the first companies to introduce FDA approved NGS based genetic tests to the Turkish market. Through Valentis Health, we offer a robust portfolio of molecular diagnostic assays available both as send out and in house solutions tailored to support precision medicine in oncology and hematology. As the exclusive distributor of several cutting edge technologies, including the IsoFlux System™ for circulating tumor cell (CTC) detection, our company Gemini Gen plays a key role in cancer diagnostics and monitoring. The unit also collaborates on scientific studies and TÜBİTAK supported research projects that advance diagnostic technologies in Türkiye. Our Istanbul based wet lab, PeraLabs, provides advanced testing capabilities for genetic disease evaluation, CTC analysis, and other molecular tests. Built on scientific rigor and technological innovation, PeraLabs aims to accelerate accurate diagnosis and personalized treatment planning. With our strong diagnostic infrastructure and deep scientific partnerships, Valentis Group is committed to reshaping the future of diagnostics in Türkiye and beyond.
For more information, feel free to contact our group companies:
Valentis Health: genetik@valentis.com.tr
PeraLabs: info@peralabs.com.tr
Gemini Gen: info@geminigen.com.tr